9.04 USD
-0.12 (-1.31%)
9.04 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to INFU. INFU was compared to 102 industry peers in the Health Care Providers & Services industry. INFU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. INFU has a correct valuation and a medium growth rate. These ratings would make INFU suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year INFU was profitable.
In the past year INFU had a positive cash flow from operations.
In the past 5 years INFU has always been profitable.
In the past 5 years INFU always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 5.03%, INFU is doing good in the industry, outperforming 76.47% of the companies in the same industry.
INFU has a better Return On Equity (9.30%) than 69.61% of its industry peers.
With a decent Return On Invested Capital value of 9.55%, INFU is doing good in the industry, outperforming 78.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INFU is significantly below the industry average of 9.61%.
The last Return On Invested Capital (9.55%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROIC | 9.55% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
Looking at the Profit Margin, with a value of 3.63%, INFU is in the better half of the industry, outperforming 71.57% of the companies in the same industry.
INFU's Profit Margin has been stable in the last couple of years.
INFU's Operating Margin of 7.35% is fine compared to the rest of the industry. INFU outperforms 72.55% of its industry peers.
In the last couple of years the Operating Margin of INFU has grown nicely.
INFU has a better Gross Margin (54.55%) than 77.45% of its industry peers.
In the last couple of years the Gross Margin of INFU has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
INFU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for INFU has been increased compared to 1 year ago.
Compared to 5 years ago, INFU has more shares outstanding
INFU has a better debt/assets ratio than last year.
2.2 Solvency
INFU has an Altman-Z score of 3.48. This indicates that INFU is financially healthy and has little risk of bankruptcy at the moment.
INFU has a better Altman-Z score (3.48) than 71.57% of its industry peers.
The Debt to FCF ratio of INFU is 1.97, which is an excellent value as it means it would take INFU, only 1.97 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.97, INFU belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that INFU is not too dependend on debt financing.
The Debt to Equity ratio of INFU (0.48) is better than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Altman-Z | 3.48 |
ROIC/WACC1.07
WACC8.91%
2.3 Liquidity
INFU has a Current Ratio of 2.19. This indicates that INFU is financially healthy and has no problem in meeting its short term obligations.
INFU has a better Current ratio (2.19) than 80.39% of its industry peers.
A Quick Ratio of 1.84 indicates that INFU should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.84, INFU is doing good in the industry, outperforming 75.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 333.33%, which is quite impressive.
INFU shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
Looking at the last year, INFU shows a small growth in Revenue. The Revenue has grown by 7.22% in the last year.
The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)333.33%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%37.5%
Revenue 1Y (TTM)7.22%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%3.31%
3.2 Future
The Earnings Per Share is expected to grow by 68.50% on average over the next years. This is a very strong growth
Based on estimates for the next years, INFU will show a small growth in Revenue. The Revenue will grow by 7.05% on average per year.
EPS Next Y195.8%
EPS Next 2Y104.8%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue Next Year5.86%
Revenue Next 2Y4.76%
Revenue Next 3Y5.87%
Revenue Next 5Y7.05%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 34.77 indicates a quite expensive valuation of INFU.
INFU's Price/Earnings is on the same level as the industry average.
INFU's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.50.
Based on the Price/Forward Earnings ratio of 21.55, the valuation of INFU can be described as rather expensive.
INFU's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.93. INFU is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.77 | ||
| Fwd PE | 21.55 |
4.2 Price Multiples
75.49% of the companies in the same industry are more expensive than INFU, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, INFU is valued a bit cheaper than 78.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.74 | ||
| EV/EBITDA | 8.91 |
4.3 Compensation for Growth
INFU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INFU may justify a higher PE ratio.
INFU's earnings are expected to grow with 68.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)3.28
EPS Next 2Y104.8%
EPS Next 3Y68.5%
5. Dividend
5.1 Amount
INFU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
9.04
-0.12 (-1.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners76.15%
Inst Owner Change-2.42%
Ins Owners4.8%
Ins Owner Change0.34%
Market Cap183.87M
Revenue(TTM)134.86M
Net Income(TTM)5.07M
Analysts83.64
Price TargetN/A
Short Float %0.81%
Short Ratio0.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.14%
Min EPS beat(2)75.49%
Max EPS beat(2)226.8%
EPS beat(4)3
Avg EPS beat(4)69.56%
Min EPS beat(4)-48.06%
Max EPS beat(4)226.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)-0.46%
Revenue beat(16)7
Avg Revenue beat(16)-1.59%
PT rev (1m)3.27%
PT rev (3m)6.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)11.54%
EPS NY rev (3m)13.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.77 | ||
| Fwd PE | 21.55 | ||
| P/S | 1.31 | ||
| P/FCF | 13.74 | ||
| P/OCF | 6.92 | ||
| P/B | 3.37 | ||
| P/tB | 4.21 | ||
| EV/EBITDA | 8.91 |
EPS(TTM)0.26
EY2.88%
EPS(NY)0.42
Fwd EY4.64%
FCF(TTM)0.66
FCFY7.28%
OCF(TTM)1.31
OCFY14.45%
SpS6.88
BVpS2.68
TBVpS2.15
PEG (NY)0.18
PEG (5Y)3.28
Graham Number3.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROCE | 12.09% | ||
| ROIC | 9.55% | ||
| ROICexc | 9.63% | ||
| ROICexgc | 11.06% | ||
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% | ||
| FCFM | 9.57% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexgc growth 3Y31.39%
ROICexgc growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Debt/EBITDA | 1.12 | ||
| Cap/Depr | 99.64% | ||
| Cap/Sales | 9.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 113.02% | ||
| Profit Quality | 263.84% | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z | 3.48 |
F-Score9
WACC8.91%
ROIC/WACC1.07
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)333.33%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%37.5%
EPS Next Y195.8%
EPS Next 2Y104.8%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.22%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%3.31%
Revenue Next Year5.86%
Revenue Next 2Y4.76%
Revenue Next 3Y5.87%
Revenue Next 5Y7.05%
EBIT growth 1Y159.69%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year322.6%
EBIT Next 3Y71.57%
EBIT Next 5YN/A
FCF growth 1Y355.58%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y157.31%
OCF growth 3Y3.76%
OCF growth 5Y8.08%
INFUSYSTEM HOLDINGS INC / INFU FAQ
Can you provide the ChartMill fundamental rating for INFUSYSTEM HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INFU.
Can you provide the valuation status for INFUSYSTEM HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to INFUSYSTEM HOLDINGS INC (INFU). This can be considered as Fairly Valued.
How profitable is INFUSYSTEM HOLDINGS INC (INFU) stock?
INFUSYSTEM HOLDINGS INC (INFU) has a profitability rating of 7 / 10.
What is the financial health of INFUSYSTEM HOLDINGS INC (INFU) stock?
The financial health rating of INFUSYSTEM HOLDINGS INC (INFU) is 7 / 10.
What is the expected EPS growth for INFUSYSTEM HOLDINGS INC (INFU) stock?
The Earnings per Share (EPS) of INFUSYSTEM HOLDINGS INC (INFU) is expected to grow by 195.8% in the next year.